検索結果

R&D Pipeline | Research & Development | SENJU Pharmaceutica

PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) PranoprofeninflammationApplication under review (Vietnam) SJP-0135GlaucomaApproval（Japan） SJP-0132Dry ey

Mytear HARD LENS WETTING SOLUTION | OTC Products, etc. | Products | SENJU Pharmaceutical

ION Lubricates lenses, allows smooth insertion CHARACTERISTICS Viscous liquid forms a thin layer on the surface of hard or rigid gas permeable lenses. It alleviates the impact of lenses touching the c...

Publications | Research & Development | SENJU Pharmaceutica

5 特集　各動物種における網膜電図検査法とその評価：ウサギにおける網膜電図検査法（非臨床安全性研究） 政次 美紀、厚見 育代 比較眼科研究, 2024;43:16-20 Enhancement of therapeutic efficacy of Brinzolamide for Glaucoma by nanocrystallization and tyloxapol addition Shuy...

NewMytear CL Vitaclear Cool | OTC Products, etc. | Products | SENJU Pharmaceutical

lieves tired eyes after intense use Before using eye drops while wearing soft contact lenses, check the instructions on the box and package insert and only use the eye drops if you can confirm that th...

で失明の主 な原因となっています 8。日本では、約 10 万人が罹患していると推定されており、これまでに承認された治療法はありません でした 2,3。 参考文献 1 Boyer DS, et al. The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the comp...